Key Statistics
Market Cap$1.98M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.88
52W High$5.50
52W Low$0.58
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
Employees—
Price Performance
1 Week+10.24%
3 Month-41.04%
1 Year-63.55%
FinancialsAnnual · QuiverQuant
Revenue$4.14M
Assets$14.11M
Liabilities$2.02M
Net Income$7.90M
About
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze INM with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.